MiMedx Group, Inc. (MDXG)
Largest Insider Buys in Sector
MDXG Stock Price History Chart
MDXG Stock Performance
About MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Insider Activity of MiMedx Group, Inc.
Over the last 12 months, insiders at MiMedx Group, Inc. have bought $35,787 and sold $659,218 worth of MiMedx Group, Inc. stock.
On average, over the past 5 years, insiders at MiMedx Group, Inc. have bought $338,110 and sold $837,315 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DOUG RICE (Chief Financial Officer) — $71,573.
The last purchase of 5,000 shares for transaction amount of $35,787 was made by DOUG RICE (Chief Financial Officer) on 2023‑11‑21.
List of Insider Buy and Sell Transactions, MiMedx Group, Inc.
| 2024-03-13 | Sale | Hulse William Frank IV | General Counsel and CAO | 20,381 0.0139% | $7.95 | $162,029 | -10.18% | |
| 2024-02-20 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,271 0.0131% | $8.01 | $122,351 | -9.08% | |
| 2024-02-16 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,493 0.0133% | $8.07 | $125,075 | -8.93% | |
| 2024-02-15 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,198 0.013% | $8.06 | $122,496 | -10.56% | |
| 2024-02-14 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,845 0.0132% | $8.03 | $127,267 | -8.61% | |
| 2023-11-21 | DOUG RICE | Chief Financial Officer | 5,000 0.0043% | $7.16 | $35,787 | +8.73% | ||
| 2023-06-23 | Capper Joseph H | Chief Executive Officer | 42,025 0.037% | $6.50 | $273,331 | +17.52% | ||
| 2023-06-22 | Capper Joseph H | Chief Executive Officer | 57,975 0.0504% | $6.33 | $367,104 | +18.98% | ||
| 2023-05-16 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 10,365 0.009% | $5.95 | $61,627 | +25.54% | |
| 2023-05-15 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 3,607 0.0032% | $6.15 | $22,170 | +23.76% | |
| 2023-05-10 | Sale | Carlson Peter M | Chief Financial Officer | 5,976 0.0051% | $5.93 | $35,414 | +23.60% | |
| 2023-05-10 | Sale | Hulse William Frank IV | General Counsel and CAO | 5,870 0.005% | $5.93 | $34,786 | +23.60% | |
| 2023-05-10 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 5,869 0.005% | $5.93 | $34,780 | +23.60% | |
| 2023-05-10 | Sale | Phelan William Lawrence | Chief Accounting Officer | 1,595 0.0014% | $5.93 | $9,452 | +23.60% | |
| 2023-05-04 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 51,756 0.0437% | $5.34 | $276,470 | +35.53% | |
| 2023-05-02 | Sale | Phelan William Lawrence | Chief Accounting Officer | 5,200 0.0045% | $3.80 | $19,739 | +96.59% | |
| 2023-04-25 | Sale | Carlson Peter M | Chief Financial Officer | 6,094 0.0054% | $3.74 | $22,816 | +104.64% | |
| 2023-04-25 | Sale | Hulse William Frank IV | General Counsel and CAO | 5,988 0.0054% | $3.74 | $22,419 | +104.64% | |
| 2023-04-25 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 5,987 0.0054% | $3.74 | $22,415 | +104.64% | |
| 2023-04-25 | Sale | Phelan William Lawrence | Chief Accounting Officer | 1,628 0.0015% | $3.74 | $6,095 | +104.64% |
Insider Historical Profitability
| Hulse William Frank IV | General Counsel and CAO | 479959 0.3923% | $6.67 | 0 | 8 | |
| Whitlow Ricci S | Chief Operating Officer | 401050 0.371% | $6.67 | 0 | 4 | |
| DOUG RICE | Chief Financial Officer | 102200 0.0878% | $6.67 | 1 | 0 | |
| Okumus Fund Management Ltd. | 10 percent owner | 10533355 9.0511% | $6.67 | 0 | 2 | |
| PETIT PARKER H | Chairman & CEO | 5009121 4.3042% | $6.67 | 9 | 1 | +25.79% |
| WRIGHT TIMOTHY R | Chief Executive Officer | 1711324 1.4705% | $6.67 | 0 | 4 | |
| KOOB CHARLES E | director | 1312306 1.1276% | $6.67 | 3 | 1 | +51.39% |
| MILLER MATTHEW JERGESEN | EVP | 1134397 0.9748% | $6.67 | 0 | 5 | |
| Carlson Peter M | Chief Financial Officer | 656435 0.5641% | $6.67 | 0 | 8 | |
| Eichler Kurt M | director | 574576 0.4937% | $6.67 | 2 | 0 | |
| Taylor William Charles | President and COO | 467424 0.4016% | $6.67 | 1 | 19 | +61.76% |
| GORLIN STEVE | director | 451857 0.3883% | $6.67 | 29 | 9 | +51.19% |
| Kashyap Rohit | President, WC & Surgical | 430072 0.3696% | $6.67 | 0 | 2 | |
| Stein Robert Benjamin | President, Regenerative Med. | 317803 0.2731% | $6.67 | 0 | 12 | |
| Turner Scott M | SVP, Operations & Procurement | 226643 0.1947% | $6.67 | 0 | 3 | |
| MCCAW ROBERTA L | General Counsel and Secretary | 193247 0.1661% | $6.67 | 1 | 1 | +85.11% |
| Phelan William Lawrence | Chief Accounting Officer | 184219 0.1583% | $6.67 | 0 | 7 | |
| Rooke Andrew K. Jr. | director | 155166 0.1333% | $6.67 | 1 | 0 | |
| Graves Mark | SVP & Chief Compliance Officer | 133608 0.1148% | $6.67 | 0 | 3 | |
| PAPASAN LARRY W | director | 127320 0.1094% | $6.67 | 2 | 1 | +51.39% |
| Capper Joseph H | Chief Executive Officer | 100000 0.0859% | $6.67 | 2 | 0 | +18.25% |
| BLESER JOSEPH G | director | 76085 0.0654% | $6.67 | 4 | 0 | <0.0001% |
| Culumber Michael J. | Chief Financial Officer | 42000 0.0361% | $6.67 | 1 | 0 | +69.23% |
| Haden Alexandra O | General Counsel & Secretary | 40528 0.0348% | $6.67 | 1 | 0 | +12.23% |
| Evans Charles Robert | director | 31878 0.0274% | $6.67 | 1 | 0 | +6.06% |
| DEWBERRY J TERRY | director | 16666 0.0143% | $6.67 | 1 | 0 | |
| YESTON NEIL | director | 5000 0.0043% | $6.67 | 1 | 0 | +61.62% |
| Edwards Ken Cleon | former Dir, Pres. & Treas. | 0 0% | $6.67 | 0 | 1 |
Institutional Investor Ownership
| Essex Woodlands Management Inc | $217.1M | 19.1 | 28.2M | 0% | +$0 | 63.1 | |
| BlackRock | $70.6M | 6.21 | 9.17M | -3.82% | -$2.81M | <0.01 | |
| The Vanguard Group | $45.6M | 4.01 | 5.92M | -9.81% | -$4.96M | <0.01 | |
| State Street | $38.06M | 3.35 | 4.94M | +20.87% | +$6.57M | <0.01 | |
| Paradigm Capital Management Inc Ny | $30.1M | 2.65 | 3.91M | +13.94% | +$3.68M | 1.44 | |
| Trigran Investments, Inc. | $25.08M | 2.21 | 3.26M | New | +$25.08M | 2.43 | |
| Geode Capital Management | $20.18M | 1.78 | 2.62M | +3.26% | +$637,525.26 | <0.01 | |
| Cannell Capital LLC | $18.74M | 1.65 | 2.43M | -1.91% | -$365,557.50 | 4.41 | |
| Morgan Stanley | $14.85M | 1.31 | 1.93M | +21.48% | +$2.63M | <0.01 | |
| Renaissance Technologies | $13.53M | 1.19 | 1.76M | +40.33% | +$3.89M | 0.02 | |
| Royal Bank of Canada | $9.75M | 0.86 | 1.27M | +17.31% | +$1.44M | <0.01 | |
| Charles Schwab | $9.02M | 0.79 | 1.17M | +3.28% | +$286,440.00 | <0.01 | |
| Richmond Brothers, Inc. | $8.45M | 0.74 | 1.1M | -21.89% | -$2.37M | 15.72 | |
| Northern Trust | $8.1M | 0.71 | 1.05M | -2.27% | -$188,110.99 | <0.01 | |
| Prudential Financial | $7.98M | 0.7 | 1.04M | +10.43% | +$753,060.00 | 0.01 | |
| Arrowstreet Capital, Limited Partnership | $7.16M | 0.63 | 930,149 | +0.82% | +$58,164.60 | 0.01 | |
| Federated Hermes | $7.02M | 0.62 | 911,364 | +12.88% | +$800,730.72 | 0.02 | |
| ROYCE & ASSOCIATES INC | $6.9M | 0.61 | 896,616 | +3.96% | +$262,739.39 | 0.06 | |
| Dimensional Fund Advisors | $6.77M | 0.6 | 879,379 | +321.32% | +$5.16M | <0.01 | |
| Two Sigma | $5.8M | 0.51 | 753,740 | +21.56% | +$1.03M | 0.01 | |
| Two Sigma Advisers LP | $5.79M | 0.51 | 751,500 | +4.2% | +$233,310.00 | 0.01 | |
| Qube Research & Technologies | $5.66M | 0.5 | 734,933 | +68.03% | +$2.29M | 0.01 | |
| Susquehanna International Group | $4.83M | 0.43 | 627,721 | +46.89% | +$1.54M | 0.01 | |
| Punch & Associates Investment Management, Inc. | $4.81M | 0.42 | 624,180 | New | +$4.81M | 0.28 | |
| Goldman Sachs | $4.81M | 0.42 | 624,887 | +28.78% | +$1.08M | <0.01 | |
| Franklin Templeton Investments | $4.47M | 0.39 | 580,534 | +748.45% | +$3.94M | <0.01 | |
| Russell Investments Group Ltd | $4.25M | 0.37 | 551,546 | +5.04% | +$203,949.94 | 0.01 | |
| Hillsdale Investment Management Inc. | $3.75M | 0.33 | 486,500 | +8.62% | +$297,220.00 | 0.31 | |
| Invesco | $3.68M | 0.32 | 477,641 | +5.08% | +$177,854.57 | <0.01 | |
| Deutsche Bank | $3.61M | 0.32 | 469,149 | +0.35% | +$12,551.00 | <0.01 | |
| Bank of America | $3.51M | 0.31 | 456,290 | -16.46% | -$692,253.10 | <0.0001 | |
| Apricus Wealth Llc | $3.48M | 0.31 | 451,945 | +0.44% | +$15,400.00 | 2.45 | |
| Citigroup | $3.11M | 0.27 | 403,875 | +292.63% | +$2.32M | <0.01 | |
| BNY Mellon | $2.88M | 0.25 | 374,237 | -6.72% | -$207,568.91 | <0.01 | |
| Disciplined Growth Investors Inc Mn | $2.71M | 0.24 | 351,923 | +11.34% | +$275,875.59 | 0.05 | |
| Fisher Asset Management Llc | $2.55M | 0.23 | 331,456 | -4.31% | -$114,837.79 | <0.01 | |
| Prelude Capital | $2.39M | 0.21 | 310,971 | +5.51% | +$125,024.92 | 0.17 | |
| Connor Clark & Lunn Investment Management Ltd | $2.39M | 0.21 | 310,852 | -21.38% | -$650,896.29 | 0.01 | |
| Nuveen | $2.35M | 0.21 | 305,664 | 0% | +$0 | <0.01 | |
| Isthmus Partners, LLC | $2.32M | 0.2 | 301,500 | +39.45% | +$656,725.30 | 0.26 | |
| Divisadero Street Capital Management Lp | $2.31M | 0.2 | 300,000 | -76.78% | -$7.64M | 0.54 | |
| Marshall Wace | $2.28M | 0.2 | 295,595 | -10.83% | -$276,422.24 | <0.01 | |
| Rafferty Asset Management Llc | $2.22M | 0.2 | 288,271 | +58.66% | +$820,643.01 | 0.01 | |
| GlobeFlex Capital | $2.19M | 0.19 | 284,666 | -9.7% | -$235,489.08 | 0.22 | |
| UBS | $2.14M | 0.19 | 278,309 | +16.07% | +$296,719.60 | <0.01 | |
| Wellington Management Company | $2.06M | 0.18 | 267,192 | +134.6% | +$1.18M | <0.0001 | |
| Swiss National Bank | $1.76M | 0.16 | 228,900 | 0% | +$0 | <0.01 | |
| Parsons Capital Management Inc Ri | $1.75M | 0.15 | 227,146 | 0% | +$0 | 0.12 | |
| Calamos Advisors LLC | $1.66M | 0.15 | 216,064 | -39.23% | -$1.07M | 0.01 | |
| Cubist Systematic Strategies | $1.58M | 0.14 | 204,988 | +42.3% | +$469,168.82 | 0.01 |